0.9449USD-6.45%Mkt Cap: 31.79M USDP/E: —Last update: 2026-06-01
Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of novel and differentiated therapies for the treatment of cancer. The company was formerly known as MEI Pharma, Inc. and changed it…
Industry Peers
BiotechnologyIndicators:|
Key Statistics
Company
Market Cap31.79M USD
Enterprise Value26.82M USD
Revenue (TTM)—
Gross Profit-1.97M USD
Net Income (TTM)-15.95M USD
Revenue/Share—
Last Price0.9449 USD
Fiscal Year EndJun 2025
MR QuarterMar 2026
Employees4
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG2.22
EV/EBITDA-1.57
EV/Revenue—
P/S—
P/B0.45
EPS (TTM)-2.08
EPS (Forward)—
52W Range
0.91990% of range9.000
52W High9.000 USD
52W Low0.9199 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-94.18%
ROA-87.20%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-20.84M USD
CapEx (TTM)—
FCF Margin—
FCF Yield-42.21%
Net Debt-7.54M USD
Net Debt/EBITDA0.44
Balance Sheet
Debt/Equity—
Current Ratio11.53
Quick Ratio7.92
Book Value/Sh2.233 USD
Cash/Share0.2220 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div DateNov 16, 2023
Pay DateDec 6, 2023
Splits
Last Split1:20
Split DateApr 17, 2023
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.34.03M
Float26.43M
Insiders11.96%
Institutions17.32%
Short Interest
Short Ratio0.2d
Short % Float0.26%
Short % Out.0.23%
Shares Short77.10K
Short (prev mo.)65.14K
Technical
SMA 501.149 (-17.8%)
SMA 2001.873 (-49.5%)
Beta0.08
S&P 52W Chg27.94%
Avg Vol (30d)385.12K
Avg Vol (10d)526.44K
Technical Indicators
RSI (14)36.2
MACD-0.0408
MACD Signal-0.0225
MACD Hist.-0.0183
BB Upper1.286 USD
BB Middle1.125 USD
BB Lower0.9648 USD
BB Width28.55%
ATR (14)0.0653 USD
Vol Ratio (20d)0.51x